1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Radiotherapy Market by Technology, Brachytherapy, & Systemic Radiotherapy, Product, & Application - Global Forecasts to 2020

The global radiotherapy market is expected to reach USD 7,544.8 million by 2020 from USD 5,585.0 million in 2015, at a CAGR of 6.2% between 2015 and 2020. North America is expected to hold the largest share of the global radiotherapy market in 2015. By product, application, and technology, the radiotherapy market is broadly segmented into external beam radiotherapy, internal radiotherapy/brachytherapy, and systemic radiation therapy. The external beam radiotherapy segment accounts for the largest share of the radiotherapy market in 2015, and is expected to grow at the highest rate.

Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global radiotherapy market in 2015, followed by Europe. Asia-Pacific radiotherapy market is poised to witness highest growth rate during the forecast period from 2015 to 2020 due to a number of factors including improving healthcare infrastructure and supportive government activities.

Market growth is majorly driven by the technological advancements in radiotherapy products, rise in number of geriatric population, increasing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and growing adoption of radiotherapy devices and procedures.

As of 2014, the global radiotherapy market was dominated by Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), and Accuray Incorporated (U.S.), which together held a share of 84.5% of the overall radiotherapy market. New product launches & product enhancements; agreements, collaborations, partnerships, and contracts; geographic expansions; strategic acquisitions; and others (awareness campaigns and offering research fund & grants) are the major strategies adopted by most market players to achieve growth in the global radiotherapy market.


Reasons to Buy the Report:
From an insight perspective, this research report has focused on various levels of analysis —market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the radiotherapy market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on radiotherapy products offered by the top 10 players in the radiotherapy devices market. The report analyzes the radiotherapy market by product, application, and technology

- Product Development/Innovation: Detailed insights on current and upcoming technologies, research and development activities, product enhancements, and new product launches in the radiotherapy market

- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various radiotherapy devices across four geographies

- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the radiotherapy market

Table Of Contents

Radiotherapy Market by Technology, Brachytherapy, and Systemic Radiotherapy, Product, and Application - Global Forecasts to 2020
TABLE OF CONTENTS

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 19
1.5 LIMITATIONS 19
1.6 STAKEHOLDERS 19
2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 21
2.1.2.1 Breakdown of primaries 22
2.1.2.2 Key data from primary sources 22
2.1.2.3 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 24
2.2.1.1 Bottom-up approach 24
2.2.1.2 Top-down approach 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 26
2.4 RESEARCH ASSUMPTIONS 27
3 EXECUTIVE SUMMARY 28
3.1 INTRODUCTION 28
3.2 CURRENT SCENARIO 29
3.3 FUTURE OUTLOOK 30
3.4 CONCLUSION 32
4 PREMIUM INSIGHTS 33
4.1 GLOBAL RADIOTHERAPY MARKET (2015-2020) 33
4.2 GLOBAL RADIOTHERAPY MARKET SIZE, BY PRODUCT (2015 VS. 2020) 34
4.3 EXTERNAL BEAM RADIATION THERAPY MARKET, BY TECHNOLOGY (2015 VS. 2020) 35
4.4 GLOBAL RADIOTHERAPY MARKET SIZE, BY APPLICATION (2015) 36
?
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET SEGMENTATION 37
5.2.1 RADIOTHERAPY MARKET, BY PRODUCT 37
5.2.2 RADIOTHERAPY MARKET, BY TECHNOLOGY 38
5.2.3 RADIOTHERAPY MARKET, BY APPLICATION 39
5.3 MARKET DYNAMICS 40
5.3.1 DRIVERS 41
5.3.1.1 Technological advancements 41
5.3.1.2 Growing number of cancer patients 41
5.3.1.3 Rapidly increasing aging population 42
5.3.1.4 Rising adoption of radiotherapy devices and procedures 43
5.3.1.5 Increasing number of symposiums spreading awareness about the benefits of radiotherapy 44
5.3.2 RESTRAINTS 46
5.3.2.1 Lack of adequate infrastructure and healthcare expenditure 46
5.3.2.2 Shortage of trained personnel 46
5.3.2.3 Unfavourable healthcare reforms in the United States 47
5.3.3 OPPORTUNITIES 48
5.3.3.1 Emerging markets offer numerous growth opportunities 48
5.3.3.2 Increasing demand for cancer treatment driving investments in radiotherapy 48
5.3.4 CHALLENGES 49
5.3.4.1 Difficulty in visualizing tumors 49
5.3.4.2 Affordability and accessibility of treatment 50
6 RADIOTHERAPY MARKET, BY PRODUCT 51
6.1 INTRODUCTION 52
6.2 EXTERNAL BEAM RADIATION THERAPY 53
6.2.1 INTRODUCTION 53
6.2.2 ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS (LINAC) 54
6.2.3 COMPACT ADVANCED RADIOTHERAPY SYSTEMS 55
6.2.3.1 Introduction 55
6.2.3.2 CyberKnife 56
6.2.3.3 Gamma Knife 57
6.2.3.4 TomoTherapy 57
6.2.4 PROTON THERAPY SYSTEMS 58
6.2.4.1 Cyclotron 60
6.2.4.2 Synchrotron 61
6.3 INTERNAL RADIATION THERAPY 62
6.3.1 INTRODUCTION 62
6.3.2 SEEDS 63
6.3.3 APPLICATORS AND AFTERLOADERS 64
6.3.4 ELECTRONIC BRACHYTHERAPY 65
6.4 SYSTEMIC RADIATION THERAPY 66
7 RADIOTHERAPY MARKET, BY TECHNOLOGY 67
7.1 INTRODUCTION 68
7.2 EXTERNAL BEAM RADIATION THERAPY 69
7.2.1 INTRODUCTION 69
7.2.2 IMAGE-GUIDED RADIOTHERAPY (IGRT) 71
7.2.3 INTENSITY MODULATED RADIOTHERAPY (IMRT) 72
7.2.4 STEREOTACTIC TECHNOLOGY 73
7.2.5 PARTICLE/PROTON BEAM THERAPY 74
7.2.6 TOMOTHERAPY 75
7.2.7 3D-CONFORMAL RADIOTHERAPY (3D-CRT) 76
7.2.8 VOLUMETRIC MODULATED ARC THERAPY 77
7.3 INTERNAL BEAM RADIATION THERAPY 78
7.3.1 INTRODUCTION 78
7.3.2 LOW-DOSE RATE RADIOTHERAPY 79
7.3.3 HIGH DOSE RATE RADIOTHERAPY 80
7.4 SYSTEMIC RADIATION THERAPY 81
8 GLOBAL RADIOTHERAPY MARKET, BY APPLICATION 82
8.1 INTRODUCTION 83
8.2 EXTERNAL BEAM RADIATION THERAPY 84
8.2.1 INTRODUCTION 84
8.2.2 PROSTATE CANCER 86
8.2.3 BREAST CANCER 87
8.2.4 LUNG CANCER 88
8.2.5 HEAD AND NECK CANCER 89
8.2.6 COLORECTAL CANCER 90
8.2.7 OTHERS 91
8.3 INTERNAL RADIATION THERAPY/BRACHYTHERAPY 92
8.3.1 INTRODUCTION 92
8.3.2 PROSTATE CANCER 94
8.3.3 GYNECOLOGICAL CANCER 95
8.3.4 BREAST CANCER 96
8.3.5 CERVICAL CANCER 97
8.3.6 PENILE CANCER 98
8.3.7 OTHERS 99
?
9 RADIOTHERAPY MARKET, BY REGION 100
9.1 INTRODUCTION 101
9.2 NORTH AMERICA 103
9.3 EUROPE 109
9.4 ASIA-PACIFIC 115
9.5 REST OF THE WORLD (ROW) 122
9.5.1 LATIN AMERICA 127
9.5.2 MIDDLE EAST 128
9.5.3 AFRICA 129
10 COMPETITIVE LANDSCAPE 130
10.1 OVERVIEW 130
10.2 MARKET SHARE ANALYSIS 131
10.3 COMPETITIVE SITUATION AND TRENDS 133
10.3.1 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS 134
10.3.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS 135
10.3.3 MERGERS AND ACQUISITIONS 136
10.3.4 GEOGRAPHIC EXPANSIONS 137
10.3.5 OTHER DEVELOPMENTS 138
11 COMPANY PROFILES 139
(Overview, Financials, Products and Services, Strategy, and Developments)*
11.1 INTRODUCTION 139
11.2 VARIAN MEDICAL SYSTEMS, INC. 140
11.3 ELEKTA AB 146
11.4 ACCURAY INCORPORATED 153
11.5 IBA (ION BEAM APPLICATIONS SA) 156
11.6 NORDION, INC. 160
11.7 C. R. BARD, INC. 162
11.8 ISORAY MEDICAL, INC. 164
11.9 RAYSEARCH LABORATORIES AB 166
11.10 MEVION MEDICAL SYSTEMS, INC. 169
11.11 MITSUBISHI ELECTRIC CORPORATION 171
*Details on Financials, Product and Services, Strategy, and Developments might not be captured in case of unlisted companies.
12 APPENDIX 173
12.1 DISCUSSION GUIDE* 173
12.2 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 177
12.3 AVAILABLE CUSTOMIZATIONS 177
12.4 RELATED REPORTS 178


LIST OF TABLES

TABLE 1 RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 52
TABLE 2 EXTERNAL BEAM RADIATION THERAPY MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 53
TABLE 3 EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 53
TABLE 4 ELECTRON-EMITTING HIGH-ENERGY LINEAR ACCELERATORS MARKET SIZE,
BY REGION, 2013-2020 (USD MILLION) 54
TABLE 5 COMPACT ADVANCED RADIOTHERAPY SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 55
TABLE 6 COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 55
TABLE 7 CYBERKNIFE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 56
TABLE 8 GAMMA KNIFE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 57
TABLE 9 TOMOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 58
TABLE 10 PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 59
TABLE 11 PROTON THERAPY SYSTEMS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 59
TABLE 12 CYCLOTRON MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 60
TABLE 13 SYNCHROTRON MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 61
TABLE 14 INTERNAL RADIATION THERAPY/BRACHYTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 62
TABLE 15 INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 62
TABLE 16 SEEDS MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 63
TABLE 17 APPLICATORS AND AFTERLOADERS MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 64
TABLE 18 ELECTRONIC BRACHYTHERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 65
TABLE 19 SYSTEMIC RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 66
TABLE 20 RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 68
TABLE 21 EXTERNAL BEAM RADIATION THERAPY MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 70
TABLE 22 EXTERNAL BEAM RADIATION THERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 70
TABLE 23 IMAGE-GUIDED RADIOTHERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 71
TABLE 24 INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 72
TABLE 25 STEREOTACTIC TECHNOLOGY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 73
TABLE 26 PARTICLE/PROTON BEAM MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 74
TABLE 27 TOMOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 75
TABLE 28 3-D CONFORMAL RADIOTHERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 76
TABLE 29 VOLUMETRIC ARC RADIOTHERAPY MARKET SIZE, BY REGION,
2013-2020 (USD MILLION) 77
TABLE 30 INTERNAL RADIATION THERAPY/BRACHYTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 78
TABLE 31 INTERNAL RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 79
TABLE 32 LOW DOSE RATE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 79
TABLE 33 HIGH DOSE RATE MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 80
TABLE 34 SYSTEMIC RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 81
TABLE 35 RADIOTHERAPY MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 83
TABLE 36 EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 84
TABLE 37 PROSTATE CANCER MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 86
TABLE 38 BREAST CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 87
TABLE 39 LUNG CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 88
TABLE 40 HEAD AND NECK CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 89
TABLE 41 COLORECTAL CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 90
TABLE 42 OTHER CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 91
TABLE 43 INTERNAL RADIOTHERAPY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 92
TABLE 44 PROSTATE CANCER MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION) 94
TABLE 45 GYNECOLOGICAL CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 95
TABLE 46 BREAST CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 96
TABLE 47 CERVICAL CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 97
TABLE 48 PENILE CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 98
TABLE 49 OTHER CANCER MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 99
TABLE 50 RADIOTHERAPY MARKET SIZE, BY REGION, 2013-2020 (USD MILLION) 101
TABLE 51 NORTH AMERICA: RADIOTHERAPY MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 105
TABLE 52 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 106
TABLE 53 NORTH AMERICA: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 106
TABLE 54 NORTH AMERICA: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 106
TABLE 55 NORTH AMERICA: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 107
TABLE 56 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE,
BY TECHNOLOGY, 2013-2020 (USD MILLION) 107
TABLE 57 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY MARKET SIZE,
BY TECHNOLOGY, 2013-2020 (USD MILLION) 107
TABLE 58 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 108
TABLE 59 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY MARKET SIZE,
BY APPLICATION, 2013-2020 (USD MILLION) 108
TABLE 60 EUROPE: RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 111
TABLE 61 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 112
TABLE 62 EUROPE: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 112
TABLE 63 EUROPE: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 112
TABLE 64 EUROPE: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 113
TABLE 65 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY, 2013-2020 (USD MILLION) 113
TABLE 66 EUROPE: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 113
TABLE 67 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 114
TABLE 68 EUROPE: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 114
TABLE 69 APAC: RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 118
TABLE 70 APAC: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 118
TABLE 71 APAC: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 119
TABLE 72 APAC: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 119
TABLE 73 APAC: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 119
TABLE 74 APAC: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 120
TABLE 75 APAC: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 120
TABLE 76 APAC: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 121
TABLE 77 APAC: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 121
TABLE 78 ROW: RADIOTHERAPY MARKET SIZE, BY PRODUCT, 2013-2020 (USD MILLION) 123
TABLE 79 ROW: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 124
TABLE 80 ROW: COMPACT ADVANCED RADIOTHERAPY MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 124
TABLE 81 ROW: PROTON THERAPY SYSTEMS MARKET SIZE, BY PRODUCT,
2013-2020 (USD MILLION) 124
TABLE 82 ROW: INTERNAL RADIOTHERAPY/BRACHYTHERAPY MARKET SIZE,
BY PRODUCT, 2013-2020 (USD MILLION) 125
TABLE 83 ROW: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 125
TABLE 84 ROW: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY TECHNOLOGY,
2013-2020 (USD MILLION) 126
TABLE 85 ROW: EXTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 126
TABLE 86 ROW: INTERNAL BEAM RADIOTHERAPY MARKET SIZE, BY APPLICATION,
2013-2020 (USD MILLION) 127
TABLE 87 TOP 5 NEW PRODUCT LAUNCHES AND PRODUCT ENHANCEMENTS,
2013-2015 134
TABLE 88 TOP 5 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, AND CONTRACTS, 2013-2015 135
TABLE 89 TOP MERGERS AND ACQUISITIONS, 2013-2015 136
TABLE 90 TOP 5 GEOGRAPHIC EXPANSIONS, 2013-2015 137
TABLE 91 TOP 5 OTHER DEVELOPMENTS, 2013-2015 138


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 20
FIGURE 2 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 22
FIGURE 3 RADIOTHERAPY MARKET: BOTTOM-UP APPROACH 24
FIGURE 4 RADIOTHERAPY MARKET: TOP-DOWN APPROACH 25
FIGURE 5 RADIOTHERAPY MARKET: DATA TRIANGULATION 26
FIGURE 6 GLOBAL RADIOTHERAPY MARKET, BY TECHNOLOGY, 2015 (USD MILLION) 28
FIGURE 7 GLOBAL RADIOTHERAPY MARKET, BY TECHNOLOGY, 2015 VS. 2020 30
FIGURE 8 GLOBAL RADIOTHERAPY MARKET, BY REGION, 2015 (USD MILLION) 31
FIGURE 9 ATTRACTIVE GROWTH OPPORTUNITIES IN THE RADIOTHERAPY MARKET 33
FIGURE 10 EXTERNAL BEAM THERAPY SEGMENT IS EXPECTED TO DOMINATE THE RADIOTHERAPY MARKET TILL 2020 34
FIGURE 11 VMAT AND TOMOTHERAPY ARE EXPECTED TO BE FASTEST GROWING AMONG THE KEY TECHNOLOGIES OF EXTERNAL BEAM RADIATION THERAPY MARKET 35
FIGURE 12 PROSTATE CANCER TREATMENT TO COMMAND THE LARGEST SHARE OF KEY APPLICATIONS FOR BOTH EXTERNAL AND INTERNAL RADIOTHERAPY 36
FIGURE 13 RADIOTHERAPY MARKET, BY PRODUCT 37
FIGURE 14 RADIOTHERAPY MARKET, BY TECHNOLOGY 38
FIGURE 15 RADIOTHERAPY MARKET, BY APPLICATION 39
FIGURE 16 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 40
FIGURE 17 GROWING INCIDENCES OF CANCER 42
FIGURE 18 TOTAL POPULATION VS. AGING POPULATION 43
FIGURE 19 GROWING INCIDENCES OF CANCER ARE EXPECTED TO PROPEL MARKET GROWTH 45
FIGURE 20 NUMBER OF RADIOTHERAPY UNITS IN DIFFERENT REGIONS 46
FIGURE 21 SHORTAGE OF TRAINED ONCOLOGISTS AND RADIOGRAPHERS LIMITS THE MARKET GROWTH 47
FIGURE 22 EMERGING MARKETS TO OFFER NUMEROUS OPPORTUNITIES 49
FIGURE 23 AFFORDABILITY AND ACCESSIBILITY OF RADIOTHERAPY HINDERS MARKET GROWTH 50
FIGURE 24 LINAC DOMINATES THE EXTERNAL BEAM RADIOTHERAPY SYSTEMS MARKET 52
FIGURE 25 VOLUMETRIC MODULATED ARC RADIOTHERAPY IS EXPECTED TO GROW AT THE HIGHEST CAGR DURING 2015 TO 2020 69
FIGURE 26 HIGH DOSE RATE RADIOTHERAPY IS EXPECTED TO GAIN SIGNIFICANT MARKET SHARE BY 2020 78
FIGURE 27 BREAST CANCER IS EXPECTED TO BE FASTEST GROWING AMONG THE KEY APPLICATIONS OF EXTERNAL BEAM RADIATION THERAPY MARKET 85
FIGURE 28 PENILE CANCER IS EXPECTED TO BE FASTEST GROWING AMONG THE KEY APPLICATIONS OF INTERNAL RADIATION THERAPY MARKET 93
FIGURE 29 GLOBAL RADIOTHERAPY MARKET SHARE (%) AND SIZE (USD MILLION) 102
FIGURE 30 NORTH AMERICAN RADIOTHERAPY MARKET SNAPSHOT 103
FIGURE 31 HIGH ADOPTION OF ADVANCED RADIOTHERAPY TECHNOLOGIES DRIVES THE NORTH AMERICAN RADIOTHERAPY MARKET 104
FIGURE 32 EUROPEAN RADIOTHERAPY MARKET SNAPSHOT 109
FIGURE 33 GROWING INCIDENCES OF CANCER LEADING TO INCREASED DEMAND FOR RADIOTHERAPY PROCEDURES IN THE EUROPEAN REGION 110
FIGURE 34 ASIA-PACIFIC RADIOTHERAPY MARKET SNAPSHOT 115
FIGURE 35 KEY MARKET PLAYERS TO EXPAND THEIR PRESENCE IN THE ASIA-PACIFIC REGION 116
FIGURE 36 REST OF THE WORLD RADIOTHERAPY MARKET SNAPSHOT 122
FIGURE 37 GROWING INCIDENCES OF CANCER IN THE ROW REGION IS LEADING TO INCREASING DEMAND FOR RADIOTHERAPY PROCEDURES 123
FIGURE 38 LEADING MARKET PLAYERS ADOPTED BOTH ORGANIC AND INORGANIC GROWTH STRATEGIES OVER THE LAST THREE YEARS (2013-2015) 130
FIGURE 39 GLOBAL RADIOTHERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2014 131
FIGURE 40 GEOGRAPHIC REVENUE MIX OF THE TOP FOUR MARKET PLAYERS* (2014) 139
FIGURE 41 VARIAN MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT 140
FIGURE 42 ELEKTA AB: COMPANY SNAPSHOT 146
FIGURE 43 ACCURAY INCORPORATED: COMPANY SNAPSHOT 153
FIGURE 44 IBA: COMPANY SNAPSHOT 156
FIGURE 45 C.R. BARD, INC.: COMPANY SNAPSHOT 162
FIGURE 46 ISORAY MEDICAL, INC.: COMPANY SNAPSHOT 164
FIGURE 47 RAYSEARCH LABORATORIES AB: COMPANY SNAPSHOT 166
FIGURE 48 MITSUBISHI ELECTRIC CORPORATION: COMPANY SNAPSHOT 171

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Non-Small Cell Lung Cancer (NSCLC) - Global Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung ...

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by GlobalData

Non-Small Cell Lung Cancer (NSCLC) - 5EU Drug Forecast and Market Analysis to 2025 Summary Lung cancer is currently is the most common cause of death from cancer worldwide. Of total lung cancer incident ...

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers

  • $ 6400
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $9,800.  DataPack (test volumes, sales forecasts, supplier shares) $6,400. Highlights Comprehensive 620-page analysis of the US tumor marker testing market.Major issues pertaining to the ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.